Press Releases

AdvaMed Applauds Congressional Passage of CARES Act

WASHINGTON, D.C. – Today, AdvaMed President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

“These are extraordinary times, and we appreciate Congress for responding in an extraordinary way,” said Scott Whitaker, President and CEO of AdvaMed. “The latest relief package will help keep medical technology manufacturers afloat in the face of economic turmoil, and it will enable them to operate at the highest possible levels to combat COVID-19. Patients and the global health care system are counting on our industry to continue delivering the tools they need to prevent, diagnose, and treat this disease. Thanks to quick action by Congress and the administration, we feel even more confident in our ability to do just that. Still, many small medical technology companies may need additional help, and we look forward to working with Congress and the administration on that front as they consider future relief legislation.”

The CARES Act includes several key provisions to aid medical technology manufacturers.

Additionally, CARES includes several positive tax and payment relief provisions for medical technology manufacturers.


# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.